Drug giants drop suit against South African drug law

Sibbald, Barbara
May 2001
CMAJ: Canadian Medical Association Journal;5/29/2001, Vol. 164 Issue 11, p1608
Academic Journal
Reports that international drug companies have withdrawn their challenge to a South African law that will allow the government to import or produce generic versions of patented drugs. How Africans suffering from HIV and AIDS cannot afford the patented drugs; Suggestion that other countries will follow South Africa's lead; Involvement of the World Health Organization in the case.


Related Articles

  • Pharmaceutical policy in Italy. Garattini, Livio; Cornago, Dante // European Journal of Health Economics;Jun2006, Vol. 7 Issue 2, p89 

    The author reflects on the pharmaceutical policy in the health care system of Italy. The author opines that, previously, the pharmaceutical expenditure is regulated through price schemes and continuous reviews of the national list of reimbursable drugs. The recent policy is focusing on a...

  • REGISTRATION OF PHARMACEUTICALS IN ISRAEL AND ITS EXEMPTIONS. Yahalom, Zohar; Shani, Segev // Medicine & Law (World Association for Medical Law);2004, Vol. 23 Issue 2, p379 

    The requirement to obtain a preliminary approval for every pharmaceutical product in order to allow its regular distribution is an accepted practice worldwide. In Israel, the preliminary approval is known as registration in the national drug registry. The mechanism of drug registration has been...

  • In brief.  // BMJ: British Medical Journal (International Edition);4/2/2005, Vol. 330 Issue 7494, p746 

    Presents news briefs related to medical care and world health. Approval of an Indian law which will permit pharmaceutical patents; Report that former professor Eric Poehlman admitted to falsifying data on several U.S. federal grant applications; Increase in the incidence of avian influenza;...

  • EU Is Expected To Adopt Bolar Drug Provisions. Milmo, Sean // Chemical Market Reporter;03/27/2000, Vol. 257 Issue 13, p8 

    Reports on the plan of the European Union to adopt a drug provision which allows the development of generic drugs before patents. Information on the provision; Details on national regulations governing generic drugs; Impact of the provision to the pharmaceutical industry.

  • WHO/UNICEF Technical Briefing Seminar: increasing understanding of the pharmaceutical sector in developing countries.  // Essential Drugs Monitor;2005, Issue 34, p28 

    The article highlights the 9th Technical Briefing Seminar for International Staff Active in Pharmaceutical Support Programmes held in Geneva, Switzerland on September 19-23, 2005. Participants from 23 countries were exposed to a wide range of technical issues confronting the pharmaceutical...

  • The 14th WHO Model List of Essential Medicines.  // WHO Technical Report Series;2005, Issue 933, p54 

    The article presents the 14th World Health Organization's 14th Model List of Essential Medicines. It discusses the concept of essential medicines, the procedures for updating the Model List, selection criteria, quality assurance, and the promotion of rational use of essential medicines. The...

  • Do Consumer-Targeted Rx Ads Improve Treatment? Lewis, Carol // Consumers' Research Magazine;Jun2003, Vol. 86 Issue 6, p27 

    Examines whether consumer-targeted prescription advertisements improve medical treatment in the U.S. Opinion of physicians on direct-to-consumer advertisements; Cause of the practice of drug manufacturers to promote their products to consumers; Ways in which the Food and Drug Administration...

  • UNDERSTANDING THE ABPI CODE OF CONDUCT. Tiner, Richard // Pulse;5/10/2007, Vol. 67 Issue 18, p64 

    The article focuses on the importance of understanding the code of conduct set by the Association of the British Pharmaceutical Industry (ABPI)in maintaining good medical practice in Great Britain. The ABPI code has many requirements about the content of promotional materials and has set...

  • Report from: Latin America. Berger, Hellen // Pharmaceutical Technology;Sep2011, Vol. 35 Issue 9, p18 

    The article offers updates related to the pharmaceutical industry in Latin America. It cites that demand for pharmaceuticals and other products have increased in the region driven by favourable regulatory measures which attract global attention. It also notes that growth in healthcare access in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics